[1]Huang DQ, Terrault NA, TackeF, et al. Global epidemiology of cirrhosis—aetiology, trends and predictions[J]. Nat Rev Gastroenterol Hepatol, 2023, 20(6): 388-398. DOI: 10.1038/s41575-023-00759-2.
[2]Tapper EB, Parikh ND. Diagnosis and management of cirrhosis and its complications: a review[J]. JAMA, 2023, 329(18): 1589-1602. DOI: 10.1001/jama.2023.5997.
[3]Gralnek IM, Duboc MC, Garcia-Pagan JC, et al. Endoscopic diagnosis and management of esophagogastric variceal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline[J]. Endoscopy, 2022, 54(11): 1094-1120. DOI: 10.1055/a-1939-4887.
[4]郝欣,刘小双,刘伟,等.超声内镜参数联合临床资料构建的列线图预测食管胃底静脉曲张治疗后再出血的价值[J].临床超声医学杂志, 2023, 25(12): 977-981. DOI: 10.3969/j.issn.1008-6978.2023.12.010.
[5]刘水澎,张国顺.彩色多普勒超声检测门静脉、脾静脉血流动力学在肝硬化食管胃底静脉曲张患者中的临床应用研究[J].中国实验诊断学, 2023, 27(4): 436-439. DOI: 10.3969/j.issn.1007-4287.2023.04.015.
[6]邢世磊,李之慧,宁秀景.乙型肝炎肝硬化并发自发性细菌性腹膜炎患者血清MCP-1、TNF-α和IL-10水平变化及其与病情复发的关系研究[J].实用肝脏病杂志, 2024, 27(4): 563-566. DOI: 10.3969/j.issn.1672-5069.2024.04.018.
[7]刘礼剑,翁欣欣,黎丽群,等.归芍五甲汤对肝硬化大鼠肝脏病理及肝纤四项、TGF-β1、TIMP-1、LPS、ALB、PT的影响[J].时珍国医国药, 2022, 33(3): 561-563. DOI: 10.3969/j.issn.1008-0805.2022.03.13.
[8]中华医学会肝病学分会,中华医学会消化病学分会,中华医学会消化内镜学分会.肝硬化门静脉高压食管胃静脉曲张出血的防治指南[J].临床肝胆病杂志, 2023, 39(3): 527-538. DOI: 10.3760/cmaj.cn501113-20220824- 00436..
[9]王宇,王民,张冠华,等.肝硬化的诊断、分期及治疗原则[J].临床肝胆病杂志,2021,37(1): 17-21. DOI: 10.3969/j.issn.1001-5256.2021.01.004.
[10]Liu YB, Chen MK. Epidemiology of liver cirrhosis and associated complications: Current knowledge and future directions[J]. World J Gastroenterol, 2022, 28(41): 5910. DOI: 10.3748/wjg.v28.i41.5910.
[11]Duan X, He X, Yan H, et al. Analysis of complications and risk factors other than bleeding before and after endoscopic treatment of esophagogastric variceal bleeding in patients with liver cirrhosis[J]. Can J Gastroenterol Hepatol, 2023, 2023(1): 7556408. DOI:10.1155/2023/7556408.
[12]Liu B, Li G. Progress in endoscopic and interventional treatment of esophagogastric variceal bleeding[J]. Dis Markers, 2022: 2940578. DOI: 10.1155/2022/2940578.
[13]杜旭芳,李超,张惠玲,等.肝硬化食管胃底静脉曲张破裂出血患者恐惧疾病进展现状及影响因素分析[J].中华现代护理杂志, 2024, 30(33): 4569-4573. DOI: 10.3760/cma.j.cn115682-20240303-01081.
[14]喻雪珂,黎孟玲,彭思远,等.食管胃底静脉曲张破裂出血对肝硬化患者1年死亡结局的影响及相关因素研究[J].中国全科医学, 2023, 26(14): 1745-1752. DOI: 10.12114/j.issn.1007-9572.2022.0730.
[15]王薇,晁霞,周道颖,等.超声内镜检查术对食管-胃底静脉曲张患者食管静脉曲张套扎术治疗效果的评价[J].中国内镜杂志, 2023, 29(5): 52-56. DOI:10.12235/E20220400.
[16]刘伟,王贺,初晓燕,等.超声定量分析技术预测食管胃底静脉曲张出血危险度的应用[J].影像科学与光化学, 2022, 40(5): 1103-1107. DOI: 10.7517/issn.1674-0475.220304.
[17]王治虹,时晨,曾壮,等.超声内镜引导下曲张静脉精准断流术治疗食管胃底静脉曲张有效性及安全性的初步研究(含视频)[J].中华消化内镜杂志, 2024, 41(7): 543-549. DOI:10.3760/cma.j.cn321463-20230419-00219.
[18]李红,胡林莉,黄树丽.超声内镜联合风险评估系统评分对肝硬化患者合并食管胃底静脉曲张破裂出血的诊断价值[J].广东医学, 2022, 43(8): 994-1000. DOI: 10.13820/j.cnki.gdyx.20212121.
[19]刘华柱,张献文,张欢,等. D-二聚体/血小板、纤维蛋白原/白蛋白预测乙肝肝硬化患者食管胃底静脉曲张破裂出血的临床价值[J].转化医学杂志, 2022, 11(3): 138-142. DOI: 10.3969/j.issn.2095-3097.2022.03.003.
[20]张志远,邓卉.基于超声及实验室参数的Logistic回归模型预测肝硬化食管胃底静脉曲张破裂出血的临床价值[J].临床超声医学杂志, 2024, 26(6): 491-495. DOI: 10.3969/j.issn.1008-6978.2024.06.015.
[21]王文静,刘宁,于艳华,等.蛋白C、蛋白S、抗凝血酶、凝血因子Ⅷ在不同Child-Pugh肝功能分级的慢性肝硬化患者中的应用研究[J].标记免疫分析与临床, 2023, 30(2): 191-194,256. DOI: 10.11748/bjmy.issn.1006-1703. 2023.02.003.
[22]赵忠乐,陈红伟,宋亚华.肝硬化食管胃底静脉曲张破裂出血的影响因素及诊断价值分析[J].现代消化及介入诊疗, 2024, 29(3): 327-330. DOI: 10.3969/j.issn.1672- 2159 .2024.03.015.
[23]黄柏盛,邓文婷,区蓝芯,等.吲哚菁绿清除试验对乙型肝炎肝硬化患者发生食管胃底静脉曲张的预测价值[J].中西医结合肝病杂志, 2023, 33(10): 869-872. DOI: 10.3969/j.issn.1005-0264.2023.010.002.
[24]安宝燕,郭清,冯明洋,等.恩替卡韦联合卡维地洛治疗乙型肝炎肝硬化合并食管胃底静脉曲张的疗效[J].肝脏, 2023, 28(6): 646-648. DOI: 10.3969/j.issn.1008-1704. 2023.06.006.
[25]何雨倩,马德强,曾伊凡,等.食管胃底静脉曲张破裂出血患者经颈静脉肝内门体分流术治疗后的疗效及生存情况分析[J].中西医结合肝病杂志, 2023, 33(9): 783-786. DOI: 10.3969/j.issn.1005-0264.2023.009.004.
|